Antistoffer mot retinoblastom-genprodukt, anvedelse derav samt murint hybridom

摘要

The present invention discloses a method of determining the prognosis of a cancer patient by determining the presence or absence of Retinoblastoma gene product in tumor antibodies which specifically bind to the hydrophilic c-terminus of the retinoblastoma protein are also provided.